“Tongxinluo preserves the renal function in diabetic kidney disease via protecting the HK-2 cells from the patterns of programmed cell death”, Bangladesh J Pharmacol, vol. 16, no. 2, pp. 52–64, Apr. 2021, doi: 10.3329/bjp.v16i2.52090.